Is LVCLF or EQR a better dividend investment in 2026?

LVCLF currently yields 25316.46% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: LVCLF offers higher current income.

What is the dividend yield difference between LVCLF and EQR?

LVCLF has a forward dividend yield of 25316.46% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 25311.73 percentage points.

Home › Compare › LVCLF vs EQR

LVCLF vs EQR: Dividend Comparison 2026

LVCLF yields 25316.46% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LVCLF wins by $545812235198788272128.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LVCLF

● Live price

25316.46%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$545812235198788272128.00M

Annual income

$541,603,839,126,149,800,000,000,000.00

Full LVCLF calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — LVCLF vs EQR

📍 LVCLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LVCLF	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LVCLF + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LVCLF pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVCLF

Annual income on $10K today (after 15% tax)

$2,151,898.73/yr

After 10yr DRIP, annual income (after tax)

$460,363,263,257,227,300,000,000,000.00/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, LVCLF beats the other by $460,363,263,257,227,300,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVCLF + EQR for your $10,000?

LVCLF: 50%EQR: 50%

100% EQR50/50100% LVCLF

Portfolio after 10yr

$272906117599394136064.00M

Annual income

$270,801,919,563,074,900,000,000,000.00/yr

Blended yield

99.23%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

LVCLF

No analyst data

Altman Z

46.9

Piotroski

2/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVCLF buys

EQR buys

No recent congressional trades found for LVCLF or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLVCLFEQR

Forward yield	25316.46% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$545812235198788272128.00M ✓	$40.5K
Annual income after 10y	$541,603,839,126,149,800,000,000,000.00 ✓	$3,819.61
Total dividends collected	$545535052761023643648.00M ✓	$16.9K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: LVCLF vs EQR ($10,000, DRIP)

Year	LVCLF Portfolio	LVCLF Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$2,542,346	$2,531,645.57	$11,248	$547.57	+$2.53M → LVCLF
2	$604,245,347	$601,525,037.18	$12,701	$666.53	+$604.23M → LVCLF
3	$134,259,526,671	$133,612,984,149.75	$14,405	$814.59	+$134259.51M → LVCLF
4	$27,889,421,383,128	$27,745,763,689,589.74	$16,413	$999.84	+$27889421.37M → LVCLF
5	$5,416,349,539,098,672	$5,386,507,858,218,725.00	$18,795	$1,232.92	+$5416349539.08M → LVCLF
6	$983,461,915,432,174,600	$977,666,421,425,338,900.00	$21,639	$1,527.95	+$983461915432.15M → LVCLF
7	$166,956,658,621,138,240,000	$165,904,354,371,625,800,000.00	$25,057	$1,903.80	+$166956658621138.22M → LVCLF
8	$26,500,723,640,478,440,000,000	$26,322,080,015,753,820,000,000.00	$29,197	$2,385.87	+$26500723640478440.00M → LVCLF
9	$3,933,080,441,718,197,000,000,000	$3,904,724,667,422,885,000,000,000.00	$34,250	$3,008.70	+$3933080441718196736.00M → LVCLF
10	$545,812,235,198,788,300,000,000,000	$541,603,839,126,149,800,000,000,000.00	$40,467	$3,819.61	+$545812235198788272128.00M → LVCLF

LVCLF vs EQR: Complete Analysis 2026

LVCLF — Stock

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer's disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the University of New South Wales, an artificial intelligence platform for biopharmaceutical prediction of both fixed dose combination drug targets and repurposed drug targets agnostic to medical indication. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.

Full LVCLF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this LVCLF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVCLF vs SCHD LVCLF vs JEPI LVCLF vs O LVCLF vs KO LVCLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.